In vitro studies including cytotoxicity studies, wound-healing assay, saturation and internalization experiments were carried out in prostate cancer cell lines expressing either PSMA (LNCaP cells) or GRPr (PC3 cells), to investigate their potential future use as SPECT/MRI diagnostic tools for PCa. The gene discussed is FOLH1; the disease is prostate carcinoma.